Fig. 4From: Evaluation of a new foetal shielding device for pregnant brain tumour patientsDose distributions and DVHs of various treatment techniques for the patient: a 6 MV VMAT, b 6 MV IMRT, c 6 MV FFF VMAT, d 6 MV FFF IMRT, e DVH for 6 MV VMAT and IMRT, and f DVH for 6 MV FFF VMAT and IMRTBack to article page